Research Institute of Molecular Pathology (IMP)
Sabrina M. Horn is a dedicated researcher specializing in biochemistry and biophysics, currently serving as a PhD student at the Research Institute of Molecular Pathology since September 2019, focusing on protein-DNA complexes. Previously, Sabrina completed a Master's thesis at the University of Copenhagen, utilizing CRISPR-Cas9 for genome-wide screenings related to O-glycan truncation. Additional experience includes internships and research positions at prestigious institutions such as EMBL, the Hospital of the University of Tübingen, and Universität Greifswald, where Sabrina gained expertise in areas like intranuclear dynamics, PCR techniques, enzyme expression optimization, and immunomodulatory effects of galectins. Sabrina holds a Master of Science and a Bachelor of Science in Biochemistry from the University of Tübingen, completed in 2019 and 2016, respectively.
This person is not in any offices
Research Institute of Molecular Pathology (IMP)
The Research Institute of Molecular Pathology (IMP) in Vienna is a basic biomedical research institute largely sponsored by Boehringer Ingelheim. With over 200 scientists from 40 countries, the IMP is committed to scientific discovery of fundamental molecular and cellular mechanisms underlying complex biological phenomena. Research areas include cell and molecular biology, microscopy, immunology and cancer, developmental biology, chromosome biology, and computational biology.